Form 4 for EWTX Edgewise Therapeutics, Inc.
Accepted 2023-06-26 00:00:00 ET · period of report 2023-06-22 · accession 0001562180-23-005500 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-26 | 2023-06-22 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.71 | +10.0K | 29.0K | +53% | +$7,100 |
| D | 2023-06-26 | 2023-06-22 | EWTX | Carruthers R Michael | CFO | M - OptEx | $0.00 | -10.0K | 197.1K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-22 | M | A | 10,000 | $0.71 | 29,024 | D | — | — | (F1) Includes 2,898 shares purchased on May 15, 2023 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 2 | Derivative | Stock Options (Right to buy) | 2023-06-22 | M | D | 10,000 | $0.00 | 197,122 | D | $0.71 · — to 2030-09-01 | 10,000 Common Stock | (F2) 1/4th of the shares subject to the option became vested and exercisable on September 1, 2021 and 1/48th of the shares subject to the option continue to vest each month, subject to the Reporting Person continuing as a service provider through each vest date. |